Harvard Bioscience (HBIO)
NASDAQ:HBIO

Harvard Bioscience Stock Price & Analysis

158 Followers

HBIO Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$2.10 - $7.36
Previous Close$2.86
Volume100.20K
Average Volume (3M)110.69K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$5.14M
Total Debt (Recent Filing)$56.91M
Price to Earnings (P/E)-16.9
Beta1.64
Next EarningsMar 08, 2023
Dividend YieldN/A
EPS (TTM)-0.17
Shares Outstanding41,657,688
R-Squared0.32
Standard Deviation0.16
10 Day Avg. Volume72,201
30 Day Avg. Volume110,690
Price to Book (P/B)-22.33
Price to Sales (P/S)1.01
Price to Cash Flow (P/CF)120.20
P/FCF Ratio-38.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside36.36% Upside
Rating ConsensusStrong Buy
Alpha-0.00567
Number of Analyst Covering3


Financials


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

HBIO FAQ

What was Harvard Bioscience’s price range in the past 12 months?
Harvard Bioscience lowest stock price was $2.10 and its highest was $7.36 in the past 12 months.
    What is Harvard Bioscience’s market cap?
    Currently, no data Available
    When is Harvard Bioscience’s upcoming earnings report date?
    Harvard Bioscience’s upcoming earnings report date is Mar 08, 2023 which is in 93 days.
      How were Harvard Bioscience’s earnings last quarter?
      Harvard Bioscience released its earnings results on Nov 08, 2022. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of $0.067 by -$0.077.
        Is Harvard Bioscience overvalued?
        According to Wall Street analysts Harvard Bioscience’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Harvard Bioscience pay dividends?
          Harvard Bioscience pays a Notavailable dividend of $1.34 which represents an annual dividend yield of N/A. Harvard Bioscience’s last Notavailable dividend payment was on Nov 01, 2013. Harvard Bioscience’s upcoming ex-dividend date is Nov 04, 2013
            What is Harvard Bioscience’s EPS estimate?
            Harvard Bioscience’s EPS estimate is $0.05.
              How many shares outstanding does Harvard Bioscience have?
              Harvard Bioscience has 41,657,690 shares outstanding.
                What happened to Harvard Bioscience’s price movement after its last earnings report?
                Harvard Bioscience reported an EPS of -$0.01 in its last earnings report, missing expectations of $0.067. Following the earnings report the stock price went down -9.504%.
                  Which hedge fund is a major shareholder of Harvard Bioscience?
                  Among the largest hedge funds holding Harvard Bioscience’s share is Harvey Partners LLC. It holds Harvard Bioscience’s shares valued at 7M.

                    ---

                    Harvard Bioscience Stock Smart Score

                    7
                    Neutral
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10
                    The Harvard Bioscience stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                    Learn more about TipRanks Smart Score

                    Company Description

                    Harvard Bioscience

                    Harvard Bioscience, Inc. develops, manufactures, and markets broad range of specialized products, primarily apparatus and scientific instruments. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.

                    ---

                    Forecast EPS vs Actual EPS


                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Chromadex
                    Standard BioTools
                    Personalis
                    Singular Genomics Systems
                    Alpha Teknova

                    Popular Stocks

                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis